These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3684175)

  • 1. Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide.
    Bezwoda WR; Mansoor N; Dansey R
    Oncology; 1987; 44(6):345-9. PubMed ID: 3684175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
    Harris AL
    Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
    Kao YC; Okubo T; Sun XZ; Chen S
    Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between tumour aromatase activity, tumour characteristics and response to therapy.
    Miller WR; Anderson TJ; Jack WJ
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1055-9. PubMed ID: 2285581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
    J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
    Santen RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging role of aromatase inhibitors in the treatment of breast cancer.
    Harvey HA
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamental research leading to improved endocrine therapy for breast cancer.
    Miller WR
    J Steroid Biochem; 1987; 27(1-3):477-85. PubMed ID: 3320538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aromatase inhibitor].
    Stein M
    Med Monatsschr Pharm; 1993 Mar; 16(3):66-7. PubMed ID: 8464387
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
    Friedrichs K; Jänicke F
    Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
    Brodie AM; Santen RJ
    Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy.
    Lawrence BV; Lipton A; Harvey HA; Santen RJ; Wells SA; Cox CE; White DS; Smart EK
    Cancer; 1980 Feb; 45(4):786-91. PubMed ID: 7357495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
    Holdaway IM
    Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of aromatase activity in human breast cancer.
    Miller WR; Hawkins RA; Forrest AP
    Cancer Res; 1982 Aug; 42(8 Suppl):3365s-3368s. PubMed ID: 7083201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of aromatase activity in human breast tumors.
    Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
    Nicholls PJ; Daly MJ; Smith HJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.